Pulmonx Gross Profit 2019-2024 | LUNG
Pulmonx Annual Gross Profit (Millions of US $) |
|
---|---|
2023 | $51 |
2022 | $40 |
2021 | $36 |
2020 | $21 |
2019 | $22 |
2018 | $12 |
Pulmonx Quarterly Gross Profit (Millions of US $) |
|
---|---|
2024-09-30 | $15 |
2024-06-30 | $15 |
2024-03-31 | $14 |
2023-12-31 | $14 |
2023-09-30 | $13 |
2023-06-30 | $13 |
2023-03-31 | $11 |
2022-12-31 | $11 |
2022-09-30 | $10 |
2022-06-30 | $10 |
2022-03-31 | $8 |
2021-12-31 | $10 |
2021-09-30 | $10 |
2021-06-30 | $9 |
2021-03-31 | $7 |
2020-12-31 | $7 |
2020-09-30 | $7 |
2020-06-30 | $1 |
2020-03-31 | $6 |
2019-12-31 | |
2019-09-30 | $6 |
2018-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.268B | $0.069B |
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $9.226B | 0.00 |
Inspire Medical Systems (INSP) | United States | $5.656B | 176.38 |
Hims & Hers Health (HIMS) | United States | $5.534B | 140.72 |
Enovis (ENOV) | United States | $2.608B | 17.68 |
Privia Health (PRVA) | United States | $2.587B | 215.60 |
IRhythm Technologies (IRTC) | United States | $2.316B | 0.00 |
Azenta (AZTA) | United States | $2.209B | 110.15 |
Omnicell (OMCL) | United States | $2.116B | 69.23 |
10x Genomics (TXG) | United States | $1.732B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.689B | 0.00 |
Schrodinger (SDGR) | United States | $1.518B | 0.00 |
Phreesia (PHR) | United States | $1.148B | 0.00 |
Butterfly Network (BFLY) | United States | $0.690B | 0.00 |
Standard BioTools (LAB) | United States | $0.596B | 0.00 |
Talkspace (TALK) | United States | $0.583B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.547B | 0.00 |
Definitive Healthcare (DH) | United States | $0.505B | 87.40 |
Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
TruBridge (TBRG) | United States | $0.247B | 71.91 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
American Well (AMWL) | United States | $0.124B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
P3 Health Partners (PIII) | United States | $0.076B | 0.00 |
HeartBeam (BEAT) | United States | $0.074B | 0.00 |
111 (YI) | China | $0.052B | 0.00 |
CareCloud (CCLD) | United States | $0.046B | 0.00 |
Outset Medical (OM) | United States | $0.044B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
Zepp Health (ZEPP) | China | $0.037B | 0.00 |
Movano (MOVE) | United States | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
MSP Recovery (LIFW) | United States | $0.013B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |